Jump to content

Welcome to the new Traders Laboratory! Please bear with us as we finish the migration over the next few days. If you find any issues, want to leave feedback, get in touch with us, or offer suggestions please post to the Support forum here.

  • Welcome Guests

    Welcome. You are currently viewing the forum as a guest which does not give you access to all the great features at Traders Laboratory such as interacting with members, access to all forums, downloading attachments, and eligibility to win free giveaways. Registration is fast, simple and absolutely free. Create a FREE Traders Laboratory account here.

Stevenvegas

Stevenvegas Trades

Recommended Posts

big big day. BWIH up nicely off news and now DCMT which closed strong signs huge Pan Asia agreement!

 

Closed strong at .58

 

Document Capture Announces Milestone Pan-Asia Licensing Agreement

http://biz.yahoo.com/bw/090209/20090209006334.html?.v=1

 

Monday February 9, 4:01 pm ET

Far Reaching Sales Agreement between DCT and China-Based Syscan Technology Holdings

 

SAN JOSE, Calif.--(BUSINESS WIRE)--Document Capture Technologies, Inc. (OTCBB:DCMT - News), an IP-driven worldwide leader in the design, development and sale of next-generation portable scanning technologies, today announced a major product sales licensing agreement with China-based company Syscan Technology Holdings (STH).

 

 

STH is a leading manufacturer and provider of 2D barcode scanning technology, products and application solutions throughout China. For ten years STH and one of its wholly owned subsidiaries have worked closely with DCT: manufacturing its products exclusively. This logical broadening of that relationship is expected to result in the expansion of the international market for DCT mobile scanners.

 

“This is a major threshold event for Document Capture as it provides significant pan-Asian market expansion for DCT’s products directly into China and Southeast Asia as well as India, Pakistan and Malaysia,” said David P. Clark, Chief Executive Officer of DCT. “The growth of the security and financial sectors in these markets, as well as those more established in Korea, Japan, and Singapore are potentially some of the fastest growing in the world. To move into these areas with such a strong partner as STH is a major step in DCT’s corporate and revenue growth.”

 

The one-year renewable agreement covers DCT’s six DocketPORT® series products, as well as future offerings currently in development. DCT will also provide STH with Software Development Kits (SDK’s) covering PC, Linux, Mac, and Win CE operating systems. In addition the two companies will work together in the defending of the IP behind these devices worldwide.

 

As a shareholder, Syscan Technology Holdings currently owns over 3 million shares of DCT common stock. It is expected that the expanded relationship between the two companies will produce mutual opportunity for ongoing market development and expansion in Asia and beyond.

 

“This is a win-win joining of forces in the manufacturing sale and market expansion of mobile scanners globally.” Cheung Wei, Chairman of STH commented. “We believe there is great opportunity in China and other emerging markets.”

 

DCT’s commitment to product innovation has resulted in demand-driven products at the forefront of the paper-to-digital revolution. The proliferation of paper-to-digital green initiatives, high security demands and accelerated financial transactions require innovative ways to digitally capture, authenticate, store, share, and manage information.

Share this post


Link to post
Share on other sites

APPY news - Update

 

Update: AspenBio Pharma to Host Conference Call to Discuss Preliminary Results of the AppyScore FDA Clinical Study on Jan. 21 at 9:00 AM ET

 

CASTLE ROCK, CO--(MARKET WIRE)--Jan 20, 2009 -- AspenBio Pharma, Inc. (NasdaqCM:APPY - News), an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, has changed the time for the conference call previously scheduled for Thursday, January 22, 2009 to now be held earlier, on Wednesday, January 21 at 9:00 a.m. Eastern time.

 

The company management will discuss initial preliminary data from its Food and Drug Administration clinical trial of AppyScore, the world's first blood-based test as an aid in the diagnosis of human appendicitis. They will also discuss status of the FDA approval, product development and commercialization of AppyScore.

 

AspenBio's Vice-Chairman Greg Pusey will host the call, with presentations by president and CEO, Richard G. Donnelly, the company's new executive chairman, Daryl J. Faulkner and Dr. John Bealer, the co-inventor of AppyScore. This will be followed by a question and answer period.

 

Please call the conference telephone number 5-10 minutes prior to the start time:

 

 

Date: Wednesday, January 21, 2009

Time: 9:00 a.m. Eastern time (6:00 a.m. Pacific time)

Dial in number, U.S./Canada Toll-free: 1-800-896-8445

International (Toll): 1-785-830-1916

Conference ID: 7ASPENBIO

 

An operator will register your name and organization and ask you to wait until the call begins. If you have any difficulty connecting with the conference call, please contact the Liolios Group at (949) 574-3860.

 

A simultaneous webcast and replay of the call will be accessible via this link: http://viavid.net/dce.aspx?sid=00005C74.

Share this post


Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


  • Topics

  • Posts

    • Date: 25th April 2024. Investors Monitor a Potential Japanese Intervention, and upcoming Tech Earnings. Meta stocks top earnings expectations, but revenue guidance for the next 6 months triggers significant selloff. Meta stocks decline 15.00% and the Magnificent Seven also trade lower. Japanese Authorities are on watch and most market experts predict the Japanese Federal Government will intervene once again. The Japanese Yen is the day’s worst performing currency while the Australian Dollar continues to top the charts. The US Dollar trades 0.10% lower, but this afternoon’s performance is likely to be dependent on the US GDP. USA100 – Meta Stocks Fall 15% On the Next 6-Months Guidance The NASDAQ has declined 1.51% over the past 24 hours, unable to maintain momentum from Monday and Tuesday. Technical analysts advise the decline is partially simply a break in the bullish momentum and the asset continues to follow a bullish correction pattern. However, if the decline continues throughout the day, the retracement scenario becomes a lesser possibility. In terms of indications and technical analysis, most oscillators, and momentum-based signals point to a downward price movement. The USA100 trades below the 75-Bar EMA, below the VWAP and the RSI hovers above 40.00. All these factors point towards a bearish trend. The bearish signals are also likely to strengthen if the price declines below $17,295.11. The stock which is experiencing considerably large volatility is Meta which has fallen more than 15.00%. The past quarter’s earnings beat expectations and according to economists, remain stable and strong. Earnings Per Share beat expectations by 8.10% and revenue was as expected. However, company expenses significantly rose in the past quarter and the guidance for the second half of the year is lower than previous expectations. These two factors have caused investors to consider selling their shares and cashing in their profits. Meta’s decline is one of the main causes for the USA100’s bearish trend. CFRA Senior Analyst, Angelo Zino, advises the selloff may be a slight over reaction based on earnings data. If Meta stocks rise again, investors can start to evaluate a possible upward correction. However, a concern for investors is that more and more companies are indicating caution for the second half of the year. The price movements will largely now depend on Microsoft and Alphabet earnings tonight after market close. Microsoft is the most influential stock for the NASDAQ and Alphabet is the third. The two make up 14.25% of the overall index. If the two companies also witness their stocks decline after the earnings reports, the USA100 may struggle to gain upward momentum. EURJPY – Will Japan Intervene Again? In the currency market, the Japanese Yen remains within the spotlight as investors believe the Japanese Federal Government is likely to again intervene. The Federal Government has previously intervened in the past 12 months which caused a sharp rise in the Yen before again declining. The government opted for this option in an attempt to hinder a further decline. Volatility within the Japanese Yen will also depend on today’s US GDP reading and tomorrow’s Core PCE Price Index. However, investors will more importantly pay close attention to the Bank of Japan’s monetary policy. Investors will be keen to see if the central bank believes it is appropriate to again hike in 2024 as well as comment regarding inflation and the economy. In terms of technical analysis, breakout levels can be considered as areas where the exchange rate may retrace or correct. Breakout levels can be seen at 166.656 and 166.333. However, the only indicators pointing to a decline are the RSI and similar oscillators which advise the price is at risk of being “overbought”. Always trade with strict risk management. Your capital is the single most important aspect of your trading business. Please note that times displayed based on local time zone and are from time of writing this report. Click HERE to access the full HFM Economic calendar. Want to learn to trade and analyse the markets? Join our webinars and get analysis and trading ideas combined with better understanding on how markets work. Click HERE to register for FREE! Click HERE to READ more Market news. Michalis Efthymiou Market Analyst HFMarkets Disclaimer: This material is provided as a general marketing communication for information purposes only and does not constitute an independent investment research. Nothing in this communication contains, or should be considered as containing, an investment advice or an investment recommendation or a solicitation for the purpose of buying or selling of any financial instrument. All information provided is gathered from reputable sources and any information containing an indication of past performance is not a guarantee or reliable indicator of future performance. Users acknowledge that any investment in FX and CFDs products is characterized by a certain degree of uncertainty and that any investment of this nature involves a high level of risk for which the users are solely responsible and liable. We assume no liability for any loss arising from any investment made based on the information provided in this communication. This communication must not be reproduced or further distributed without our prior written permission.
    • $ALVR AlloVir stock bottom breakout watch, huge upside gap, https://stockconsultant.com/?ALVR
    • $DIS Disney stock attempting to move higher off the 112.79 triple support area, https://stockconsultant.com/?DIS
    • $ADCT Adc Therapeutics stock flat top breakout watch above 5.31, https://stockconsultant.com/?ADCT
    • $CXAI CXApp stock local support and resistance areas at 2.78, 3.52 and 5.19, https://stockconsultant.com/?CXAI
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.